Informing youth-centred opioid agonist treatment: Findings from a retrospective chart review of youths' characteristics and patterns of opioid agonist treatment engagement in a novel integrated youth services program.
Kelly McInerney,Kirsten Marchand,Jennifer Elaine Buckley,Chloe Gao,Andrew Kestler,Steve Mathias,Aubree Argyle,Skye Barbic +7 more
TL;DR: In this article , a retrospective chart review was carried out on electronic medical records of 23 youth with OUD accessing a community-based integrated youth services (IYS) centre, where they were offered OAT and 83% initiated treatment with buprenorphine/naloxone, methadone, or slow-release oral morphine.
read more
Abstract: AIM
Youth ages 12-24 account for approximately 20% of overdoses and yet are poorly reached by opioid agonist treatment (OAT), the most widely recommended treatment for opioid use disorder (OUD). This study contributes to understanding this critical gap by describing youths' patterns of OAT engagement at a novel integrated youth-specific OAT program.
METHODS
A retrospective chart review was carried out on electronic medical records of n = 23 youth with OUD accessing a community-based integrated youth services (IYS) centre. Data abstraction focused on four domains: sociodemographic, social determinants of health, patterns of OAT engagement, and other services utilized.
RESULTS
Youths' mean age was 22.6 years (SD = 2.1), with a mean age of first opioid use of 17.4 (SD = 2.7). Youth reported extensive histories of adverse childhood experiences, concurrent mental and physical health complications, and poly-substance use. All youth were offered OAT and 83% initiated treatment with buprenorphine/naloxone, methadone, or slow-release oral morphine. Among those initiating OAT, 42.1% were considered stable on OAT.
CONCLUSIONS
To our knowledge, this is the first empirical study to describe youths' OAT engagement in an integrated youth-specific OAT program. Our findings demonstrated that a high proportion of youth with OUD initiated OAT in this novel program with varying degrees of OAT stability. These findings can be used to inform the development and implementation of youth-specific and integrated OAT. To account for the novelty of this area of study and small sample sizes, future collaborative efforts across IYS initiatives should be considered, including mixed method approaches to understand outcomes and experiences.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
References
Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study
Vincent J. Felitti,Robert F. Anda,Dale F. Nordenberg,David F. Williamson,Alison M. Spitz,Valerie J. Edwards,Mary P. Koss,James S. Marks +7 more
TL;DR: For example, this article found a strong relationship between the breadth of exposure to abuse or household dysfunction during childhood and multiple risk factors for several of the leading causes of death in adults.
16.3K
Our future: a Lancet commission on adolescent health and wellbeing
George C Patton,George C Patton,Susan M Sawyer,Susan M Sawyer,Susan M Sawyer,John S. Santelli,David Ross,David Ross,Rima Afifi,Nicholas B. Allen,Nicholas B. Allen,Monika Arora,Peter Azzopardi,Peter Azzopardi,Wendy Baldwin,Chris Bonell,Ritsuko Kakuma,Elissa Kennedy,Jaqueline Mahon,Terry McGovern,Ali H. Mokdad,Vikram Patel,Vikram Patel,Suzanne Petroni,Nicola J. Reavley,Kikelomo Taiwo,Jane Waldfogel,Dakshitha Wickremarathne,Carmen Barroso,Zulfiqar A Bhutta,Zulfiqar A Bhutta,Adesegun O. Fatusi,Amitabh Mattoo,Amitabh Mattoo,Judith Diers,Jing Fang,Jane Ferguson,Fred M. Ssewamala,Russell M Viner +38 more
TL;DR: This Commission outlines the opportunities and challenges for investment in adolescent health and wellbeing at both country and global levels (panel 1).
3K
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
TL;DR: Buprenorphine maintenance compared to placebo and to methadone maintenance in the management of opioid dependence, including its ability to retain people in treatment, suppress illicit drug use, reduce criminal activity, and mortality is evaluated.
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
TL;DR: Methadone is an effective maintenance therapy intervention for the treatment of heroin dependence as it retains patients in treatment and decreases heroin use better than treatments that do not utilise opioid replacement therapy, and does not show a statistically significant superior effect on criminal activity.
1.6K
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
Luis Sordo,Luis Sordo,Gregorio Barrio,María J. Bravo,B. Iciar Indave,Louisa Degenhardt,Louisa Degenhardt,Lucas Wiessing,Marica Ferri,Roberto Pastor-Barriuso +9 more
TL;DR: Retention in methadone and buprenorphine treatment is associated with substantial reductions in the risk for all cause and overdose mortality in people dependent on opioids.